330 related articles for article (PubMed ID: 33084447)
1. Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States.
Hu T; Weiss T; Owusu-Edusei K; Petigara T
J Med Econ; 2020 Dec; 23(12):1653-1660. PubMed ID: 33084447
[TBL] [Abstract][Full Text] [Related]
2. Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries.
Hu T; Weiss T; Bencina G; Owusu-Edusei K; Petigara T
J Med Econ; 2021; 24(1):1098-1107. PubMed ID: 34461796
[TBL] [Abstract][Full Text] [Related]
3. Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong.
Mohanty S; Hu T; Yang G; Khan TK; Owusu-Edusei K; Sukarom I
Hum Vaccin Immunother; 2022 Nov; 18(5):2046433. PubMed ID: 35420975
[TBL] [Abstract][Full Text] [Related]
4. Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children.
Ryman J; Sachs JR; Yee KL; Banniettis N; Weaver J; Weiss T
Expert Rev Vaccines; 2024; 23(1):60-68. PubMed ID: 38073483
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive value assessments for new pediatric pneumococcal conjugate vaccines.
Hu T; Weiss T; Bencina G; Owusu-Edusei K; Petigara T
J Med Econ; 2021; 24(1):1083-1086. PubMed ID: 34433365
[TBL] [Abstract][Full Text] [Related]
6. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
7. Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA.
Owusu-Edusei K; Deb A; Johnson KD
Infect Dis Ther; 2022 Jun; 11(3):987-999. PubMed ID: 35084647
[TBL] [Abstract][Full Text] [Related]
8. Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018.
Hu T; Song Y; Done N; Liu Q; Sarpong EM; Lemus-Wirtz E; Signorovitch J; Mohanty S; Weiss T
BMC Public Health; 2022 Sep; 22(1):1677. PubMed ID: 36064378
[TBL] [Abstract][Full Text] [Related]
9. Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States.
Huang L; Wasserman M; Grant L; Farkouh R; Snow V; Arguedas A; Chilson E; Sato R; Perdrizet J
Vaccine; 2022 Aug; 40(33):4700-4708. PubMed ID: 35753839
[TBL] [Abstract][Full Text] [Related]
10. Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children.
Ryman J; Weaver J; Yee KL; Sachs JR
Expert Rev Vaccines; 2022 Oct; 21(10):1515-1521. PubMed ID: 35997125
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014-2018.
Hu T; Song Y; Done N; Mohanty S; Liu Q; Sarpong EM; Lemus-Wirtz E; Signorovitch J; Weiss T
BMC Health Serv Res; 2023 Apr; 23(1):398. PubMed ID: 37098521
[TBL] [Abstract][Full Text] [Related]
12. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
Andrews N; Kent A; Amin-Chowdhury Z; Sheppard C; Fry N; Ramsay M; Ladhani SN
Vaccine; 2019 Jul; 37(32):4491-4498. PubMed ID: 31272872
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
[TBL] [Abstract][Full Text] [Related]
15. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541
[TBL] [Abstract][Full Text] [Related]
16. Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
Macaj M; Perdochova L; Jakubikova J
Vaccine; 2023 Jan; 41(2):452-459. PubMed ID: 36470684
[TBL] [Abstract][Full Text] [Related]
17. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
18. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
[TBL] [Abstract][Full Text] [Related]
19. Invasive Pneumococcal Disease After 2 Decades of Pneumococcal Conjugate Vaccine Use.
Yildirim I; Lapidot R; Shaik-Dasthagirisaheb YB; Hinderstein S; Lee H; Klevens M; Grant L; Arguedas Mohs AG; Cane A; Madoff L; Johnson H; Ivanof C; Burns M; Pelton S
Pediatrics; 2024 Jan; 153(1):. PubMed ID: 38087952
[TBL] [Abstract][Full Text] [Related]
20. Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous Australians.
Meder KN; Jayasinghe S; Beard F; Dey A; Kirk M; Cook H; Strachan J; Sintchenko V; Smith H; Giele C; Howden B; Krause V; Mcintyre P
Clin Infect Dis; 2020 Jun; 70(12):2607-2615. PubMed ID: 31388670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
